Papers in JHEP Reports
Page 13 · newest first
- Safety of naltrexone in patients with cirrhosisJHEP Reports · 2024
- Gut Bifidobacterium longum is associated with better native liver survival in patients with biliary atresiaJHEP Reports · 2024
- Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic eventsJHEP Reports · 2024
- Lack of association between early on-treatment HBeAg seroclearance and development of hepatocellular carcinoma or decompensated cirrhosisJHEP Reports · 2024
- Insulin resistance is an integral feature of MASLD even in the presence of PNPLA3 variantsJHEP Reports · 2024
- Durability and on-treatment predictors of recompensation in entecavir-treated patients with hepatitis B and decompensated cirrhosisJHEP Reports · 2024
- PPP1R15A-expressing monocytic MDSCs promote immunosuppressive liver microenvironment in fibrosis-associated hepatocellular carcinomaJHEP Reports · 2024
- Glutamine metabolism, a double agent combating or fuelling hepatocellular carcinomaJHEP Reports · 2024
- Paediatric hepatocellular adenomas: Lessons from a systematic review of relevant literatureJHEP Reports · 2024
- Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohortJHEP Reports · 2024
- Glycogen synthase kinase 3 activity enhances liver inflammation in MASHJHEP Reports · 2024
- Proportion of pregnant women with HBV infection eligible for antiviral prophylaxis to prevent vertical transmission: A systematic review and meta-analysisJHEP Reports · 2024
- Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patientsJHEP Reports · 2024
- Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtideJHEP Reports · 2024
- CXCR6+CD69+ CD8+ T cells in ascites are associated with disease severity in patients with cirrhosisJHEP Reports · 2024
- Interleukin-7-based identification of liver lymphatic endothelial cells reveals their unique structural featuresJHEP Reports · 2024
- Metabolome-wide association identifies altered metabolites and metabolic pathways in the serum of patients with cholangiocarcinomaJHEP Reports · 2024
- The Impact of Stigma on Quality of Life and Liver Disease Burden Among Patients with Nonalcoholic Fatty Liver DiseaseJHEP Reports · 2024
- Recommendations on maximising the clinical value of tissue in the management of patients with intrahepatic cholangiocarcinomaJHEP Reports · 2024
- Maternal obesity increases the risk of hepatocellular carcinoma through the transmission of an altered gut microbiomeJHEP Reports · 2024
- Enhanced liver fibrosis (ELF) score predicts hepatic decompensation and mortalityJHEP Reports · 2024
- Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trialJHEP Reports · 2024
- Xanthine oxidase promotes hepatic lipid accumulation through high fat absorption by the small intestineJHEP Reports · 2024
- CTLA-4 haplotype predicts HBsAg and HBcrAg levels and HBeAg seroconversion age in children with chronic HBV infectionJHEP Reports · 2024
- Validation of NIAAAm-CRP criteria to predict alcohol-associated steatohepatitis on liver histologyJHEP Reports · 2024
- Soluble urokinase plasminogen activator receptor levels predict survival in patients with portal hypertension undergoing TIPSJHEP Reports · 2024
- Immediate postpartum cessation of tenofovir did not increase risk of virological or clinical relapse in highly viremic pregnant mothers with chronic hepatitis B infectionJHEP Reports · 2024
- Predictive role of hepatic venous pressure gradient in bleeding events among patients with cirrhosis undergoing orthotopic liver transplantationJHEP Reports · 2024
- Reevaluating cirrhotic cardiomyopathy diagnosticsJHEP Reports · 2024
- Adverse pregnancy outcomes as a risk factor for new-onset metabolic dysfunction-associated steatotic liver disease in postpartum women: A nationwide studyJHEP Reports · 2024
- Investigating shared genetic architecture between inflammatory bowel diseases and primary biliary cholangitisJHEP Reports · 2024
- Preclinical evaluation of therapeutic vaccines for chronic hepatitis B that stimulate antiviral activities of T cells and NKT cellsJHEP Reports · 2024
- Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational studyJHEP Reports · 2024
- Time to broaden the screening strategy for chronic hepatitis B virus infection beyond the emergency departmentJHEP Reports · 2024
- Operating under pressure: Is there a place for preoperative TIPS?JHEP Reports · 2024
- Orphan receptor GPR176 in hepatic stellate cells exerts a profibrotic role in chronic liver diseaseJHEP Reports · 2024
- Reply to: “Comment on <Integrating an addiction team into the management of patients transplanted for alcohol-associated liver disease reduces the risk of severe relapse>”JHEP Reports · 2024
- Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in patients following DAA failureJHEP Reports · 2024
- Oxytocin alleviates liver fibrosis via hepatic macrophagesJHEP Reports · 2024
- Liver specification of human iPSC-derived endothelial cells transplanted into mouse liverJHEP Reports · 2024
- A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinomaJHEP Reports · 2024
- Hepatitis B surface antigen expression impairs endoplasmic reticulum stress-related autophagic flux by decreasing LAMP2JHEP Reports · 2024
- Global and regional burden of alcohol-associated liver disease and alcohol use disorder in the elderlyJHEP Reports · 2024
- Platelet-derived thrombospondin 1 promotes immune cell liver infiltration and exacerbates diet-induced steatohepatitisJHEP Reports · 2024
- CD14 facilitates perinatal human cytomegalovirus infection in biliary epithelial cells via CD55JHEP Reports · 2024
- Infections increase the risk of decompensation and death in patients with early alcohol-related liver diseaseJHEP Reports · 2024
- Laminin 511-E8, an autoantigen in IgG4-related cholangitis, contributes to cholangiocyte protectionJHEP Reports · 2024
- Natural antibodies are required for clearance of necrotic cells and recovery from acute liver injuryJHEP Reports · 2024
- Targeting thrombospondin-2 retards liver fibrosis by inhibiting TLR4-FAK/TGF-β signalingJHEP Reports · 2024
- Effect of plasma exchange with albumin replacement on albumin functionality and organ dysfunction in acute-on-chronic liver failureJHEP Reports · 2024